Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  C-Rad AB (publ)    CRAD B   SE0002016352

C-RAD AB (PUBL)

(CRAD B)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
01/15/2021 01/18/2021 01/19/2021 01/20/2021 01/21/2021 Date
46.6(c) 46.5(c) 45.5(c) 46.7(c) 47.15 Last
23 169 11 818 23 827 15 467 21 098 Volume
-0.96% -0.21% -2.15% +2.64% +0.96% Change
More quotes
Financials
Sales 2018 190 M 23,0 M 23,0 M
Net income 2018 21,2 M 2,56 M 2,56 M
Net cash position 2018 9,33 M 1,13 M 1,13 M
P/E ratio 2018 37,9x
Yield 2018 -
Sales 2019 205 M 24,8 M 24,8 M
Net income 2019 -13,8 M -1,67 M -1,67 M
Net cash position 2019 6,83 M 0,82 M 0,82 M
P/E ratio 2019 -98,9x
Yield 2019 -
Capitalization 1 572 M 188 M 190 M
EV / Sales 2018 4,12x
EV / Sales 2019 6,69x
Nbr of Employees 56
Free-Float 66,7%
More Financials
Company
C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the... 
More about the company
All news about C-RAD AB (PUBL)
01/18C RAD : Web Presentation Year-end Report 2020
AQ
2020C RAD : receives order for proton cancer treatment centers in the US
AQ
2020C RAD : Shenzhen proton therapy treatment center selects C-RAD Catalyst™ s..
AQ
2020C RAD : 15 percent growth in order intake and record high operating profit
AQ
2020C RAD : Web Presentation Interim Report Q3 2020
AQ
2020C RAD : Australian customers select C-RAD's cutting edge SIGRT solution
AQ
2020C RAD : Shanghai Proton and Heavy Ion Hospital decides for C-RAD SIGRT solution
AQ
2020C RAD : and Elekta expand cooperation - Elekta to distribute C-RAD's cutting-edg..
AQ
2020C RAD PUBL : Positive operating income in challenging times
AQ
2020C RAD PUBL : RAD Web Presentation Half-Year Report 2020
AQ
2020C RAD PUBL : DTZ Berlin selects C-RAD's cutting-edge SIGRT solution
AQ
2020C RAD PUBL : RAD is seleted to equip the Shenzhen proton therapy treatment enter..
AQ
2020C RAD PUBL : Former employee has filed a lawsuit for compensation
AQ
2020C RAD PUBL : RAD AB - Interim report January - Marh 2020
AQ
2020C RAD PUBL : RAD Web Presentation Interim Report Q1 2020
AQ
More news
News in other languages on C-RAD AB (PUBL)

- No features available -

More news
Chart C-RAD AB (PUBL)
Duration : Period :
C-Rad AB (publ) Technical Analysis Chart | CRAD B | SE0002016352 | MarketScreener
Technical analysis trends C-RAD AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers and Directors
NameTitle
Tim Thurn President & Chief Executive Officer
Lars Gunnar Nyberg Chairman
Hakan Axelsson Chief Operating Officer
Henrik Bergentoft Chief Financial Officer
Peter Hamberg Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
C-RAD AB (PUBL)-3.11%188
THERMO FISHER SCIENTIFIC8.93%204 446
DANAHER CORPORATION6.71%168 395
INTUITIVE SURGICAL, INC.-2.39%93 876
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.7.26%83 588
ILLUMINA, INC.9.06%58 917